Evidence map›Paper›PMID 39162532›Full record

ArticleMicrobiology spectrum2024

The emergence of metronidazole-resistant

Yukitaka Ito, Yusuke Hashimoto, Masato Suzuki, Naomi Kaneko, Mieko Yoshida, Haruo Nakayama, Haruyoshi Tomita

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Prevalence of metronidazole resistance genes inJournal of Indian Society of Periodontology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yukitaka Ito *Division of Clinical Microbiology Laboratory, Toho University Ohashi Medical Center, Meguro, Tokyo, Japan.ORCID 0000-0002-9188-3798
Yusuke Hashimoto *Department of Bacteriology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.ORCID 0000-0002-1086-9995
Masato SuzukiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Higashimurayama, Tokyo, Japan.ORCID 0000-0001-8975-2193
Naomi KanekoDivision of Clinical Microbiology Laboratory, Toho University Ohashi Medical Center, Meguro, Tokyo, Japan.
Mieko YoshidaDivision of Clinical Microbiology Laboratory, Toho University Ohashi Medical Center, Meguro, Tokyo, Japan.
Haruo NakayamaDivision of Clinical Microbiology Laboratory, Toho University Ohashi Medical Center, Meguro, Tokyo, Japan.
Haruyoshi TomitaDepartment of Bacteriology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.ORCID 0000-0001-9969-2235

Funding

Japan Agency for Medical Research and Development (AMED) JP23fk0108604,JP24fk0108665Japan Agency for Medical Research and Development (AMED) JP23gm1610003,JP23fk0108665,JP23wm0225029Japanese Ministry of Health, Labor and Welfare 21KA1004,24KA1005Ministry of Education, Culture, Sports, Science and Technology (MEXT) 22K07067Ministry of Education, Culture, Sports, Science and Technology (MEXT) 22K16368
6 · The paper itself

Abstract

We present the identification and characterization of the complete genome of metronidazole (MTZ)-resistant IMPORTANCE: Metronidazole (MTZ) is an important antimicrobial agent in anaerobic infections and is widely used in clinical settings. The rate of MTZ resistance in anaerobic bacteria has been increasing in recent years, and the

Indexed as

Anti-Bacterial AgentsBacteroidaceae InfectionsDrug Resistance, BacterialMetronidazoleMicrobial Sensitivity TestsPrevotellaAgedBacterial ProteinsDNA Transposable ElementsFemaleGenome, BacterialHumansInterspersed Repetitive SequencesJapanWhole Genome SequencingAnti-Bacterial AgentsBacterial ProteinsDNA Transposable ElementsMetronidazolemetronidazolemobile genetic element (MGE)nimKPrevotella biviawhole-genome sequencing (WGS)

Identifiers

PMID39162532
PMCPMC11448248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.